Scott Habig - Aug 1, 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Commercial Officer
Signature
/s/ Scott Habig
Stock symbol
AUPH
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/1/2022, 04:13 PM
Previous filing
Jul 19, 2022
Next filing
Nov 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Stock Option (right to buy) Award $0 +231K $0.00 231K Aug 1, 2022 Common Stock 231K $8.18 Direct F1
transaction AUPH Restricted Stock Units Award $0 +138K $0.00 138K Aug 1, 2022 Common Shares 138K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.